Talking about recommended age or fewer doses: what motivates HPV vaccination timeliness?
| Autor: | William A. Calo, Marjorie A. Margolis, Melissa B. Gilkey, Parth D. Shah, Susan Alton Dailey, Noel T. Brewer |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Parents
Pharmacology Health Knowledge Attitudes Practice Pediatrics medicine.medical_specialty Adolescent business.industry Papillomavirus Infections Vaccination 030231 tropical medicine Immunology Short Report Hpv vaccination Human papillomavirus vaccine 03 medical and health sciences 0302 clinical medicine Humans Immunology and Allergy Medicine Papillomavirus Vaccines 030212 general & internal medicine Child business Adolescent health |
| Zdroj: | Hum Vaccin Immunother |
| ISSN: | 2164-554X 2164-5515 |
| Popis: | HPV vaccination is recommended for U.S. adolescents at ages 11–12 and requires two versus three doses if the series is started before age 15. We evaluated how talking about recommended age or fewer doses motivates on-time HPV vaccination. Our national, online experiment randomized 1,263 parents of adolescents to view one of three messages about HPV vaccination recommendations or no message. Messages framed guidelines as recommending: vaccination at age 11–12; fewer doses for those who start vaccination at age 11–12; or, fewer doses for those who start vaccination before age 15. We then assessed parents’ preferred age for HPV vaccination, categorizing preferences of ≤12 years as on-time. Parents who viewed “at age 11–12” versus no message more often preferred on-time HPV vaccination (63% vs. 43%, p .05). Parents who viewed “fewer doses before age 15” less often preferred on-time HPV vaccination (39%, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|